JDD Buzz Series | Trichologic Evaluations at Head Spas
A new type of spa is popping up in major U.S. cities. Head spas provide a mix of spa treatments for the scalp and hair as well as potentially therapeutic treatments for dermatologic conditions that affect the scalp. Some head spas offer consultation with a trichology professional, which may include trichoscopic imaging. Dermatologists say patients …
Continue reading “JDD Buzz Series | Trichologic Evaluations at Head Spas”
JDD Buzz Series | Insurance Coverage of Hair Loss Treatments
Dermatologists have several prescription treatment options for hair loss, including minoxidil, spironolactone, finasteride, and latanoprost. Yet despite the commonality of hair loss, insurance coverage of hair loss treatments is rare. An editorial published in the August Journal of Drugs in Dermatology assesses the differences in insurance coverage of these hair loss medications. I interviewed author …
Continue reading “JDD Buzz Series | Insurance Coverage of Hair Loss Treatments”
JDD September 2025 Issue Highlights | Special Focus: Aesthetic Treatments
Welcome to “JDD September 2025 Issue Highlights,” your guided tour through this month’s must-read studies, curated by the Journal of Drugs in Dermatology Editorial Team. This issue features a Special Focus on Aesthetic Treatments alongside cutting-edge research in novel pharmacotherapies, advanced procedural techniques, and safety assessments. Whether you’re dialing in volumization with poly-L-lactic acid or …
Continue reading “JDD September 2025 Issue Highlights | Special Focus: Aesthetic Treatments”
Alopecia Universalis: Never Give Up?
INTRODUCTION Alopecia universalis is a type of alopecia areata (AA) characterized by total body hair loss. The mechanism of this loss is primarily due to autoimmune disruption of the hair follicle. AA has historically been treated with corticosteroids, minoxidil, and other immune therapies that possess limited efficacy with high recurrence rates and adverse effects.1 However, in …
JDD Buzz Series | Skin of Color Representation in Pre-Clerkship Dermatology Curriculum
Medical school dermatology curriculum is known for its lack of representation of images of skin of color. A letter to the editor published in the July Journal of Drugs in Dermatology shows the effects on diagnostic accuracy, perception, and confidence when one medical school took action to make its pre-clerkship dermatology curriculum more diverse. I …
JDD July 2025 Issue Highlights
The July 2025 issue of the Journal of Drugs in Dermatology brings together another outstanding selection of articles, offering cutting-edge insights and real-world strategies across a diverse range of dermatology topics. This month’s editor’s highlights spotlight innovative approaches to photoprotection in melasma and photodamage, emerging non-pharmaceutical solutions for female hair loss, and nuanced management of …
From the JDD Podcast Vault | From Rags to Itches: The Evolution of Topical and Systemic Options for Pruritus
Welcome to another installment of our popular “From the JDD Podcast Vault” series! This week, we’re unraveling the fascinating story behind itch management with the episode: From Rags to Itches: The Evolution of Topical and Systemic Options for Pruritus, hosted by the ever-engaging Dr. Adam Friedman. We all know that urge—“Just scratch it!” But for …
JDD June 2025 Issue Highlights | Special Focus: Acne & Rosacea
The June 2025 issue of the Journal of Drugs in Dermatology delivers a diverse and thought-provoking selection of studies that place a spotlight on acne and rosacea while spanning the latest innovations and clinical insights across the dermatology spectrum. This month’s editor’s picks feature new approaches to some of the field’s most common—and challenging—conditions, from acne-induced …
Continue reading “JDD June 2025 Issue Highlights | Special Focus: Acne & Rosacea”
JDD Buzz Series | GLP-1 Agonists and Isotretinoin
Use of GLP-1 agonists is becoming increasingly more common in the U.S. According to a 2024 poll, one in eight adults has at least tried this medication class. A brief communication published in the June Journal of Drugs in Dermatology shares concerns that could arise when a patient is concurrently on a GLP-1 agonist and …
Continue reading “JDD Buzz Series | GLP-1 Agonists and Isotretinoin”
JDD Buzz Series | AI in Dermatology Residency Applications: A Program Director’s Perspective
Applicants for dermatology residency programs are increasingly using artificial intelligence (AI) technology to write or enhance their personal statements, according to a study published in the May Journal of Drugs in Dermatology. Is this ethical? Should applicants disclose AI usage? What role, if any, should AI have in applications for programs, positions, and grants? I …